Dr. Michael Allen Pulsipher, MD is a pediatric oncologist in Salt Lake City, UT specializing in pediatric oncology. He graduated from Stanford University School of Medicine. Dr. Michael Allen Pulsipher, MD is affiliated with University of Utah Health.
The top procedures that Dr. Michael Allen Pulsipher, MD treated as a pediatric oncologist in Salt Lake City, UT during 2012 were hospital care and inpatient care.
Volume of procedures performed by Dr. Michael Allen Pulsipher, MD for Medicare patients.
| hospital care | 84 |
|---|---|
| inpatient care | 84 |
| Hypertension | |
|---|---|
| High Cholesterol | |
| Stroke | |
| Ischemic Heart Disease | |
| Depression | |
| Chronic Kidney Disease | |
| Asthma | |
| Osteoperosis | |
| Atrial Fibrilation | |
| Heart Failure | |
| Chronic Obstructive Pulmonary Disease | |
| Diabetes | |
| Dementia | |
| Cancer |
| Hypertension | |
|---|---|
| High Cholesterol | |
| Stroke | |
| Ischemic Heart Disease | |
| Depression | |
| Chronic Kidney Disease | |
| Asthma | |
| Osteoperosis | |
| Atrial Fibrilation | |
| Heart Failure | |
| Chronic Obstructive Pulmonary Disease | |
| Diabetes | |
| Dementia | |
| Cancer |
Volume of procedures performed by Dr. Michael Allen Pulsipher, MD for Medicare patients.
The highest averages for the top procedures that Dr. Michael Allen Pulsipher, MD treated as a pediatric oncologist in Salt Lake City, UT were hospital care and inpatient care.
| hospital care | 84 |
|---|---|
| inpatient care | 84 |
The highest averages of the most common conditions of Medicare patients that Dr. Michael Allen Pulsipher, MD treated were chronic kidney disease, hypertension, depression and high cholesterol.
| Hypertension | |
|---|---|
| High Cholesterol | |
| Stroke | |
| Ischemic Heart Disease | |
| Depression | |
| Chronic Kidney Disease | |
| Asthma | |
| Osteoporosis | |
| Heart Failure | |
| Chronic Obstructive Pulmonary Disease | |
| Diabetes | |
| Atrial Fibrillation | |
| Dementia | |
| Cancer |
Dr. Michael Allen Pulsipher, MD graduated from Stanford University School of Medicine. He completed residency at The Children's Hospital of Philadelphia. He is certified by the American Board of Pediatrics (Sub: Pediatric Hematology-Oncology) and has a state license in Utah.
Medical School: Stanford University School of Medicine
Residency: The Children's Hospital of Philadelphia
Board Certification: American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
Licensed In: Utah
Dr. Michael Allen Pulsipher, MD does not have any reviews yet, be the first to leave a review of Dr. Michael Allen Pulsipher, MD here: Leave a Review
These charts describe general payments received by Dr. Michael Allen Pulsipher, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$87,327
KYMRIAH $61,349 |
NON BRAND $4,656 |
TISAGENLECLEUCEL-T $3,975 |
PROMACTA $2,205 |
HSC835 $526 |
Other $14,617 |
|
|
$5,164
Defitelio $2,215 |
Erwinaze $125 |
$2,824 |
||||
|
$4,650
$4,650 |
||||||
|
$4,130
$4,130 |
||||||
|
$3,979
$3,979 |
||||||
|
$8,537
Ryoncil $3,125 |
ATGAM $1,200 |
Blincyto $334 |
GRAFAPEX $137 |
Restrata Wound Matrix $62 |
Other $3,679 |
| $73,199 | |
| $19,085 | |
| $10,300 | |
| $5,355 | |
| $3,848 | |
| $2,000 |
Dr. Michael Allen Pulsipher, MD has received 79 research payments totaling $1,540,147.
Michael Allen Pulsipher, MD, is Division Chief of Pediatric Hematology at Intermountain Primary Children’s Hospital, Director of the Children’s and Adolescent Cancer Initiative at Huntsman Cancer Institute, and a Presidential Chair in Pediatric Oncology and Hematology at University of Utah Health. His clinical and research focus includes allogeneic transplantation and cell therapies for acute leukemias (CAR T, NK, and viral‑specific T cells), haploidentical approaches, NGS‑MRD–guided strategies, and reduced‑toxicity transplant protocols. Dr. Pulsipher leads multiple national multicenter...
